|
Market Closed -
Nasdaq
21:00:00 10/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.1852 USD | +1.98% |
|
-2.01% | -81.48% |
| 10-16 | Tscan Therapeutics, Inc. Announces Board and Committee Changes, Effective October 13, 2026 | CI |
| 09-30 | TScan Therapeutics, Inc. Announces Departure of Chrystal Louis as Chief Medical Officer | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 12.55M | - | - | - | ||
| 68.32B | |||||
| 60.26B | |||||
| 55.86B | |||||
| 48.43B | |||||
| 45.34B |
Select your edition
All financial news and data tailored to specific country editions
